<?xml version="1.0" encoding="UTF-8"?>
<ref id="CR41">
 <label>41.</label>
 <element-citation publication-type="journal">
  <person-group person-group-type="author">
   <name>
    <surname>Wisloff</surname>
    <given-names>T</given-names>
   </name>
   <name>
    <surname>White</surname>
    <given-names>R</given-names>
   </name>
   <name>
    <surname>Dalgard</surname>
    <given-names>O</given-names>
   </name>
   <name>
    <surname>Amundsen</surname>
    <given-names>EJ</given-names>
   </name>
   <name>
    <surname>Meijerink</surname>
    <given-names>H</given-names>
   </name>
   <name>
    <surname>Lovlie</surname>
    <given-names>AL</given-names>
   </name>
   <name>
    <surname>Klovstad</surname>
    <given-names>H</given-names>
   </name>
  </person-group>
  <article-title>Economic Evaluation of Direct-Acting Antivirals for Hepatitis C in Norway</article-title>
  <source>PharmacoEconomics</source>
  <year>2018</year>
  <volume>36</volume>
  <issue>5</issue>
  <fpage>591</fpage>
  <lpage>601</lpage>
  <pub-id pub-id-type="doi">10.1007/s40273-017-0604-3</pub-id>
  <pub-id pub-id-type="pmid">29396744</pub-id>
 </element-citation>
</ref>
